None listed
Conditions
Interventions
Intervention1: Intravenous injection Pethidine: intravenous injection of dose 0.5mg/kg over 5 minutes once
Control Intervention1: intravenous injection Dexmedetomidine: administration of intravenous d
Sponsors
Sri Devaraj URS Medical College
Eligibility
Inclusion criteria
Inclusion criteria: 1.Both male and female included 2.ASA 1 and 2
Exclusion criteria
Exclusion criteria: 1.History of cardiac, renal, or hepatic disease. 2.Patients who are known allergic to study drugs. 3.Contraindication to spinal anaesthesia 4.Any need for blood transfusion during intraoperative period 5.Major procedures where heat loss due to surgical exposure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To know about the time required for cessation of shivering after the administration of study drug in patients undergoing spinal anaesthesiaTimepoint: at the point when shivering stops | — |
Secondary
| Measure | Time frame |
|---|---|
| nilTimepoint: nil | — |
Countries
India
Contacts
Public ContactDr Kiran N
Sri Devaraj URS medical college
Outcome results
None listed